tert-Butyl (2-(1-trityl-1H-imidazol-4-yl)ethyl)carbamate

Catalog No. :
ACGBCP337
CAS No. :
327160-17-8
Molecular Formula :
C29H31N3O2
Molecular Weight :
453.59

IUPAC Name:tert-butyl (2-(1-trityl-1H-imidazol-4-yl)ethyl)carbamate

tert-Butyl (2-(1-trityl-1H-imidazol-4-yl)ethyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$156.00Login to see priceInquiryInquiry
1g95%$390.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (2-(1-trityl-1H-imidazol-4-yl)ethyl)carbamate
IUPAC Nametert-butyl (2-(1-trityl-1H-imidazol-4-yl)ethyl)carbamate
Molecular FormulaC29H31N3O2
Molecular Weight453.59
SMILESO=C(OC(C)(C)C)NCCC1=CN(C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=N1
InChI KeyJFXALNDHJGZLER-UHFFFAOYSA-N
Synonym2-[1-(Triphenylmethyl)-1H-imidazol-4-yl]ethyl]-carbamic Acid 1,1-Dimethylethyl Ester;Nα-Boc-Nt-tritylhistamine;Na-Boc-Nt-tritylhistamine;tert-butyl [2-(1-trityl-1H-imidazol-4-yl)ethyl]carbamate;Carbamic acid, [2-[1-(triphenylmethyl)-1h-imidazol-4-yl]ethyl]-, 1,1-dimethylethyl ester;Carbamic acid, [2-[1-(triphenylmethyl)-1H-imidazol-4-yl]ethyl]-, 1,1-dimethylethyl ester (9CI);Nα-Boc-Nt-trityl Histamine
CAS No.327160-17-8

Synthetic Route by SureRoute

1. ACGBCP337 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCGDM107 route compound structure diagram
    ACCGDM10798870-64-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGBCP337 route product structure diagram
    ACGBCP337327160-17-8
Inquiry

2. ACGBCP337 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWZTQ394 route compound structure diagram
    ACWZTQ394195053-92-0 In Stock
  4. Then
  5. ACGBCP337 route product structure diagram
    ACGBCP337327160-17-8
Inquiry

Comments (0)